News

Sales rise as consumers seek rest

BY Michael Johnsen

Sales of sleep aids is still on the rise, driven primarily by private-label across both tablets and liquid formats. Overall, consumers purchased sleep aids to the tune of $418 million for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI. Private-label liquid sleep aids grabbed a 16% share of the category, reaching $17.7 million in sales on 1,152.9% growth. Meanwhile, store-brand sleeping aid tablets commanded a 44.8% share of the market on sales of $137.7 million, up 5.8%.

(For the complete category review, including data, click here.)

Procter & Gamble’s ZzzQuil tablets may have suffered from the strong private-label performance — sales were down by 7.8% million to $46.6 million. But on the liquid side of the business, P&G’s ZzzQuil is still putting in a strong performance with a 67.9% share of the liquids business on sales of $75.1 million and 6.4% growth.

According to the Centers for Disease Control and Prevention, an estimated 50 million to 70 million U.S. adults have a sleep or wakefulness disorder.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Bayer’s ‘Next’ big thing

BY Michael Johnsen

Bayer Diagnostics’ Contour Next portfolio has been performing exceptionally well lately, generating $12.4 million in front-end sales, up 226.6% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI. The Contour Next portfolio includes an entry meter, Contour Next EZ, for the newly diagnosed diabetic. For the experienced tester, there is the traditional Contour Next. And for the technologically savvy tester, there’s the Contour Next USB.

(For the complete category review, including data, click here.)

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Staying Gluco-Smart on the go

BY Michael Johnsen

iHealth Lab recently launched its iHealth Align, one of the world’s smallest, FDA-approved mobile blood-glucose monitors. The meter plugs directly into a smartphone and displays and stores’ readings using the iHealth Gluco-Smart app. Through the app, users can manage their readings, track insulin and share info with caregivers and supporters. Since all the data is automatically sent to the cloud, users can view their information from anywhere by logging into their online account.

(For the complete category review, including data, click here.)

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?